Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29325953 | 0.81 | IDH1 (0.34) | IDH1IDH2 | |
| SCHEMBL20814423 | 0.75 | IDH1 (0.51) | IDH1IDH2 | |
| SCHEMBL29325826 | 0.75 | PDE4A (0.50) | — | |
| SCHEMBL30054298 | 0.75 | IL1B (0.39) | — | |
| SCHEMBL29325842 | 0.75 | IL1B (0.39) | — | |
| SCHEMBL24696092 | 0.75 | IL1B (0.39) | — | |
| SCHEMBL29325869 | 0.73 | MAPK10 (0.36) | — | |
| SCHEMBL29325863 | 0.72 | IDH1 (0.32) | IDH1IDH2 | |
| SCHEMBL31127022 | 0.71 | IDH1 (0.46) | IDH1IDH2 | |
| SCHEMBL21143665 | 0.71 | IDH1 (0.46) | IDH1IDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239758-A1 | SUBSTITUTED TRIAZINE COMPOUND | NICO THERAPEUTICS, INC. | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239758-A1 | SUBSTITUTED TRIAZINE COMPOUND | NLRP3, NLRP1, PYCARD | IDH1 2485/4885IDH2 1590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.